Literature DB >> 17361394

Levo-tetrahydropalmatine attenuates cocaine self-administration and cocaine-induced reinstatement in rats.

John R Mantsch1, Shi-Jiang Li, Robert Risinger, Sarah Awad, Eric Katz, David A Baker, Zheng Yang.   

Abstract

RATIONALE: Levo-tetrahydropalmatine (l-THP) is an alkaloid constituent of plants from the botanical genera Corydalis and Stephania and is contained in many traditional Chinese herbal preparations. In addition to its low-affinity antagonism of D2 dopamine (DA) receptors, we report that l-THP functions as a higher-affinity antagonist at D1 DA receptors and interacts with D3 DA receptors, suggesting that it may be effective for the treatment of drug addiction. Accordingly, l-THP has been reported to reduce heroin craving and relapse in recovering addicts.
OBJECTIVE: This study investigated the effects of l-THP (3.75, 7.5, and 15.0 mg/kg, i.p.) on cocaine self-administration (SA) and cocaine-induced reinstatement.
MATERIALS AND METHODS: Rats were trained to self-administer cocaine and food by pressing separate response levers during sessions consisting of a multiple schedule of alternating 30-min FR4 cocaine and 15-min FR4 food reinforcement. During the cocaine components of each session, the available cocaine dose varied such that rats had access to low and high dose ranges in varying sequence on alternating days. After SA, cocaine-reinforced responding was extinguished, and effects of l-THP on cocaine-induced reinstatement (10 mg/kg, i.p.) were examined.
RESULTS: l-THP produced a rightward and downward shift in the dose-response curve for cocaine SA and attenuated cocaine-induced reinstatement. l-THP also reduced food-reinforced responding and locomotor activity. However, reductions in cocaine SA were found at doses that failed to alter food-reinforced responding, and significant effects were not observed on food responding during reinstatement.
CONCLUSIONS: These findings suggest that l-THP is potentially useful for treating cocaine addiction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17361394     DOI: 10.1007/s00213-007-0754-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.415


  43 in total

1.  Evidence for involvement of both D1 and D2 receptors in maintaining cocaine self-administration.

Authors:  D R Britton; P Curzon; R G Mackenzie; J W Kebabian; J E Williams; D Kerkman
Journal:  Pharmacol Biochem Behav       Date:  1991-08       Impact factor: 3.533

2.  [Antagonistic effect of tetrahydroproberberine homologues on alpha 1-adrenoceptor].

Authors:  Z Z Lu; X Wei; G Z Jin; Q D Han
Journal:  Yao Xue Xue Bao       Date:  1996

3.  The novel dopamine D3 receptor antagonist NGB 2904 inhibits cocaine's rewarding effects and cocaine-induced reinstatement of drug-seeking behavior in rats.

Authors:  Zheng-Xiong Xi; Amy Hauck Newman; Jeremy G Gilbert; Arlene C Pak; Xiao-Qing Peng; Charles R Ashby; Leah Gitajn; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2005-10-05       Impact factor: 7.853

4.  Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats.

Authors:  Stanislav R Vorel; Charles R Ashby; Mousumi Paul; Xinhe Liu; Robert Hayes; Jim J Hagan; Derek N Middlemiss; Geoffrey Stemp; Eliot L Gardner
Journal:  J Neurosci       Date:  2002-11-01       Impact factor: 6.167

Review 5.  The efficacy of herbal medicine--an overview.

Authors:  Edzard Ernst
Journal:  Fundam Clin Pharmacol       Date:  2005-08       Impact factor: 2.748

6.  Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

Authors:  W Billard; V Ruperto; G Crosby; L C Iorio; A Barnett
Journal:  Life Sci       Date:  1984-10-29       Impact factor: 5.037

Review 7.  Regulation of drug-taking and -seeking behaviors by neuroadaptations in the mesolimbic dopamine system.

Authors:  David W Self
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

8.  Anxiolytic-like action of orally administered dl-tetrahydropalmatine in elevated plus-maze.

Authors:  Wai Chung Leung; Hui Zheng; Michael Huen; Sek Lun Law; Hong Xue
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-08       Impact factor: 5.067

9.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.

Authors:  D Lévesque; J Diaz; C Pilon; M P Martres; B Giros; E Souil; D Schott; J L Morgat; J C Schwartz; P Sokoloff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

10.  Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A.

Authors:  Patricia Di Ciano; Rachel J Underwood; Jim J Hagan; Barry J Everitt
Journal:  Neuropsychopharmacology       Date:  2002-06-18       Impact factor: 7.853

View more
  40 in total

1.  Responses of dopaminergic, serotonergic and noradrenergic networks to acute levo-tetrahydropalmatine administration in naïve rats detected at 9.4 T.

Authors:  Xiping Liu; Zheng Yang; Rupeng Li; Jun Xie; Qian Yin; Alan S Bloom; Shi-Jiang Li
Journal:  Magn Reson Imaging       Date:  2011-11-12       Impact factor: 2.546

Review 2.  Novel pharmacotherapeutic treatments for cocaine addiction.

Authors:  Daryl Shorter; Thomas R Kosten
Journal:  BMC Med       Date:  2011-11-03       Impact factor: 8.775

Review 3.  l-tetrahydropalamatine: a potential new medication for the treatment of cocaine addiction.

Authors:  Jia Bei Wang; John R Mantsch
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.

Authors:  Hai-Ying Zhang; Guo-Hua Bi; Hong-Ju Yang; Yi He; Gilbert Xue; Jiajing Cao; Gianluigi Tanda; Eliot L Gardner; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Neuropsychopharmacology       Date:  2017-03-07       Impact factor: 7.853

5.  β-Arrestin-Biased Allosteric Modulator of NTSR1 Selectively Attenuates Addictive Behaviors.

Authors:  Lauren M Slosky; Yushi Bai; Krisztian Toth; Caroline Ray; Lauren K Rochelle; Alexandra Badea; Rahul Chandrasekhar; Vladimir M Pogorelov; Dennis M Abraham; Namratha Atluri; Satyamaheshwar Peddibhotla; Michael P Hedrick; Paul Hershberger; Patrick Maloney; Hong Yuan; Zibo Li; William C Wetsel; Anthony B Pinkerton; Lawrence S Barak; Marc G Caron
Journal:  Cell       Date:  2020-05-28       Impact factor: 41.582

6.  A meta-analysis of Chinese herbal medicine in treatment of managed withdrawal from heroin.

Authors:  Ting-ting Liu; Jie Shi; David H Epstein; Yan-Ping Bao; Lin Lu
Journal:  Cell Mol Neurobiol       Date:  2008-06-27       Impact factor: 5.046

7.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

Review 8.  Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction.

Authors:  Hongyuan Chu; Guozhang Jin; Eitan Friedman; Xuechu Zhen
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

9.  Medication of l-tetrahydropalmatine significantly ameliorates opiate craving and increases the abstinence rate in heroin users: a pilot study.

Authors:  Zheng Yang; Yong-cong Shao; Shi-jiang Li; Jian-lin Qi; Mei-jie Zhang; Wei Hao; Guo-zhang Jin
Journal:  Acta Pharmacol Sin       Date:  2008-07       Impact factor: 6.150

10.  Fenobam sulfate inhibits cocaine-taking and cocaine-seeking behavior in rats: implications for addiction treatment in humans.

Authors:  Thomas M Keck; Hong-Ju Yang; Guo-Hua Bi; Yong Huang; Hai-Ying Zhang; Ratika Srivastava; Eliot L Gardner; Amy Hauck Newman; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2013-04-25       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.